Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions
Coert J. Zuurbier, Antonius Baartscheer, Cees A. Schumacher, Jan W.T. Fiolet, Ruben Coronel
Topics & Concepts
EmpagliflozinSodium–hydrogen antiporterSodiumChemistryTransporterPharmacologyCanagliflozinGlucose transporterEndocrinologyInternal medicineMedicineBiochemistryDiabetes mellitusInsulinType 2 diabetesGeneOrganic chemistryDiabetes Treatment and ManagementPancreatic function and diabetesMetabolism, Diabetes, and Cancer